Potentiation of nerve growth factor-action by picrosides I and II, natural iridoids, in PC12D cells.
P Li, K Matsunaga, T Yamakuni, Y Ohizumi
文献索引:Eur. J. Pharmacol. 406(2) , 203-8, (2000)
全文:HTML全文
摘要
Natural iridoid, picroside I (beta-D-glucopyranoside, 1a,1b,2,5a,6, 6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1, 2-c]pyran-2-yl, 6-(3-phenyl-2-propenoate)) or II (beta-D-glucopyranoside, 1a,1b,2,5a,6, 6a-hexahydro-6-[(4-hydroxy-3-methoxybenzoyl)oxy]-1a-(hydroxymethyl )ox ireno[4,5]cyclopenta[1,2-c]pyran-2-yl) alone did not exhibit neuritogenic activity, but caused a concentration-dependent (>0.1 microM) enhancement of nerve growth factor (NGF, 2 ng/ml)-induced neurite outgrowth from PC12D cells. The picroside-induced enhancing action of NGF was abolished by GF109203X (2-[1-(3-dimethylaminopropyl)-indol-3-yl]-3-(indol-3-yl)maleimide) (0.1 microM), a protein kinase C inhibitor. Furthermore, PD98059 (2-(2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one) (20 microM), a potent mitogen-activated protein (MAP) kinase kinase inhibitor, completely blocked the picroside-induced enhancement of neurite outgrowth in the presence of NGF (2 ng/ml), suggesting that picrosides activate the MAP kinase-dependent signaling pathway. Interestingly, no increase in the expression of phosphorylated MAP kinase was observed in picroside-treated (60 microM) PC12D cells in the presence of NGF (2 ng/ml). These results suggest that picroside I or II enhances NGF-induced neurite outgrowth from PC12D cells, probably by amplifying a down-stream step of MAP kinase in the NGF receptor-mediated intracellular MAP kinase-dependent signaling pathway.
相关化合物
相关文献:
2002-08-30
[Life Sci. 71(15) , 1821-35, (2002)]
2012-01-01
[BMC Genomics 13 , 126, (2012)]
2008-06-20
[J. Chromatogr. A. 1194(2) , 257-61, (2008)]
2000-07-01
[Biol. Pharm. Bull. 23(7) , 890-2, (2000)]
1997-09-26
[J. Chromatogr. B. Biomed. Sci. Appl. 698(1-2) , 317-20, (1997)]